secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lucid Diagnostics Inc. (LUCD)
CIK:        0001799011
Form:       8-K
Filed at:   2022-08-02T23:59:59+00:00
Accession:  0001493152-22-021012
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lucid Diagnostics appoints Debra J. White as Class C director effective August 1, 2022
--------------------------------------------------------------------------------

- Debra J. White appointed to Board, replacing Aster Angagaw who resigned July 30; resignation not due to disagreement.
- White received option to purchase 80,000 shares at $2.95/share, vesting in 12 quarterly installments starting Sept 30, 2022.
- White also serves on board of parent PAVmed Inc.; joins nominating/corporate governance and audit committees.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799011/000149315222021012/0001493152-22-021012-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799011/000149315222021012/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-021012

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer